Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2012, Article ID 135281, 5 pages
http://dx.doi.org/10.1155/2012/135281
Review Article

Circulating and Disseminated Tumor Cells in the Management of Advanced Prostate Cancer

Department of Urology, Eberhard-Karls University, Hoppe Seyler-Straße 3, 72076 TÜbingen, Germany

Received 2 June 2011; Accepted 5 June 2011

Academic Editor: Maximilian Burger

Copyright © 2012 Stephan Kruck et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • David R. Yates, Morgan Roupret, Sarah J. Drouin, Eva Comperat, Sylvie Ricci, Roger Lacave, Philippe Sebe, Geraldine Cancel-Tassin, Marc-Olivier Bitker, and Olivier Cussenot, “Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy,” Prostate, vol. 72, no. 12, pp. 1382–1388, 2012. View at Publisher · View at Google Scholar
  • James A. Sioss, Rustom B. Bhiladvala, Weihua Pan, Mingwei Li, Susan Patrick, Ping Xin, Stacey L. Dean, Christine D. Keating, Theresa S. Mayer, and Gary A. Clawson, “Nanoresonator chip-based RNA sensor strategy for detection of circulating tumor cells: response using PCA3 as a prostate cancer marker,” Nanomedicine: Nanotechnology, Biology and Medicine, vol. 8, no. 6, pp. 1017–1025, 2012. View at Publisher · View at Google Scholar
  • M. Chmielewska, K. Losiewicz, P. Socha, T. Mecik-Kronenberg, and K. Wasowicz, “The application of circulating tumor cells detecting methods in veterinary oncology,” Polish Journal Of Veterinary Sciences, vol. 16, no. 1, pp. 141–151, 2013. View at Publisher · View at Google Scholar
  • Jian Zhou, Premkumar Vummidi Giridhar, Susan Kasper, and Ian Papautsky, “Modulation of aspect ratio for complete separation in an inertial microfluidic channel,” Lab On A Chip, vol. 13, no. 10, pp. 1919–1929, 2013. View at Publisher · View at Google Scholar
  • Adrian C. Herington, Jessica E. Lisle, Raphael Rutkowski, Sally-Anne Stephenson, and Inga Mertens-Walker, “Eph receptors and their ligands: Promising molecular biomarkers and therapeutic targets in prostate cancer,” Biochimica Et Biophysica Acta-Reviews On Cancer, vol. 1835, no. 2, pp. 243–257, 2013. View at Publisher · View at Google Scholar
  • Francesca Vendittelli, Giuseppe Albino, Carmela Paolillo, Cecilia Zuppi, and Ettore Capoluongo, “Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform,” Archivio Italiano di Urologia e Andrologia, vol. 85, no. 4, pp. 164–169, 2013. View at Publisher · View at Google Scholar
  • A Patrikidou, Y Loriot, J-C Eymard, L Albiges, C Massard, E Ileana, M Di Palma, B Escudier, and K Fizazi, “Who dies from prostate cancer?,” Prostate Cancer and Prostatic Disease, 2014. View at Publisher · View at Google Scholar
  • Anna Patrikidou, Laurent Brureau, Julien Casenave, Laurence Albiges, Mario Di Palma, Jean-Jacques Patard, Hervé Baumert, Pierre Blanchard, Alberto Bossi, Kyriaki Kitikidou, Christophe Massard, Karim Fizazi, Pascal Blanchet, and Yohann Loriot, “Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome,” Urologic Oncology: Seminars and Original Investigations, 2015. View at Publisher · View at Google Scholar
  • Yu Wu, Jamie R. Schoenborn, Colm Morrissey, Jing Xia, Sandy Larson, Lisha G. Brown, Xiaoyu Qu, Paul H. Lange, Peter S. Nelson, Robert L. Vessella, and Min Fang, “High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer,” The Journal of Molecular Diagnostics, 2015. View at Publisher · View at Google Scholar
  • Mengjia Qian, Diane C Wang, Hao Chen, and Yunfeng Cheng, “Detection of single cell heterogeneity in cancer,” Seminars in Cell & Developmental Biology, 2016. View at Publisher · View at Google Scholar
  • Ippokratis Messaritakis, Eleni Politaki, Athanasios Kotsakis, Eleftheria-Kleio Dermitzaki, Filippos Koinis, Eleni Lagoudaki, Anastasios Koutsopoulos, Galatea Kallergi, John Souglakos, and Vassilis Georgoulias, “Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer,” Plos One, vol. 12, no. 7, pp. e0181211, 2017. View at Publisher · View at Google Scholar
  • Ippokratis Messaritakis, Dimitris Stoltidis, Athanasios Kotsakis, Eleftheria-Kleio Dermitzaki, Fillipos Koinis, Eleni Lagoudaki, Anastasios Koutsopoulos, Eleni Politaki, Stella Apostolaki, John Souglakos, and Vassilis Georgoulias, “TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC),” Scientific Reports, vol. 7, pp. 45351, 2017. View at Publisher · View at Google Scholar
  • Ippokratis Messaritakis, Maria Sfakianaki, Chara Papadaki, Asimina Koulouridi, Nikolaos Vardakis, Filippos Koinis, Dora Hatzidaki, Nefeli Georgoulia, Athina Kladi, Athanasios Kotsakis, John Souglakos, and Vassilis Georgoulias, “Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer,” Cancer Chemotherapy and Pharmacology, 2018. View at Publisher · View at Google Scholar